The recovery strong enough that central banks might soon step back
Across European trading floors on a Thursday in early May 2021, markets hovered near historic highs — not yet claiming them, but close enough to feel their gravity. A confluence of stronger-than-expected corporate earnings and robust economic indicators suggested that the long shadow of the pandemic was beginning to lift, even as new uncertainties — around vaccine policy and central bank intentions — reminded investors that recoveries are rarely without complication. The moment captured something enduring about markets: they are less a measure of the present than a wager on what kind of future we are willing to believe in.
- European stocks climbed to within striking distance of all-time highs, with 73% of reporting companies beating profit expectations — nearly double the historical norm — creating a rare atmosphere of broad-based optimism.
- AB Inbev surged 5.2% and eurozone banks hit 14-month highs, signaling that two of the economy's most cyclically sensitive sectors were emerging from pandemic pressure with unexpected vigor.
- Vaccine IP waiver support from President Biden sent Novavax and Moderna tumbling nearly 10%, injecting a sharp reminder that policy decisions can instantly reprice entire industries.
- The Bank of England's looming policy decision cast a long shadow over London markets, with analysts warning that any hawkish pivot could push the FTSE 100 below the psychologically significant 7,000 threshold.
- British retailers Next and Superdry bucked the uncertainty, posting strong guidance and a return to growth respectively, suggesting consumer confidence was quietly rebuilding on the ground.
On a Thursday in early May, European stock markets moved cautiously higher, the STOXX 600 rising just 0.1% to 422 points — close to its all-time high of 433.61, but not yet there. The mood, however, was genuinely optimistic. Corporate earnings had arrived in force, and the numbers were better than almost anyone had expected.
Anheuser-Busch InBev led the day's movers, jumping 5.2% after a strong first-quarter report and the announcement that Michel Doukeris would succeed longtime CEO Carlos Brito. In banking, UniCredit gained 4.7% and Societe Generale rose 4.0% after both beat quarterly forecasts, lifting the eurozone banking index to its highest level in fourteen months. Of the more than half of STOXX 600 companies that had reported by that point, 73% had exceeded profit expectations — well above the historical average of 51%.
The economic data matched the earnings story. German industrial orders surged in March on domestic demand, and Britain's services sector posted its fastest growth in over seven years. Yet complications surfaced: Novavax and Moderna fell close to 10% after President Biden backed a waiver on COVID-19 vaccine intellectual property protections, threatening the pricing power that had underpinned their valuations. Telecom Italia dropped 5.3% after reports that Rome was stepping back from plans for a unified national broadband network.
In London, the FTSE 100 edged up 0.2% as traders awaited the Bank of England's policy decision. Analysts cautioned that any signal of reduced stimulus could weigh heavily on the index. Against that backdrop, retailers offered a counterpoint: Next raised its full-year profit guidance, gaining 3.0%, while Superdry rallied 12.0% on news of a return to growth. The market was telling a story of recovery — real enough, perhaps, that the institutions built to support it might soon begin stepping away.
European stock markets were treading water on Thursday, caught between caution and optimism. The broad STOXX 600 index climbed just 0.1% to settle at 422 points—close enough to its all-time high of 433.61 to feel the pull, but not quite there. The mood, though, was decidedly upbeat. A wave of corporate earnings had arrived with better-than-expected numbers, and fresh economic data from across the continent suggested the recovery was gaining real momentum.
Anheuser-Busch InBev led the charge, its stock jumping 5.2% after the brewing giant reported first-quarter results that cleared expectations. The company also announced a leadership transition: Michel Doukeris, who runs the North America business, would take over as chief executive from Carlos Brito. In the banking sector, where investors had been watching closely for signs of health, the numbers were equally reassuring. UniCredit, Italy's second-largest bank, gained 4.7%, while France's Societe Generale rose 4.0% after both reported quarterly earnings that beat forecasts. The broader eurozone banking index climbed to its highest point in fourteen months, a signal that lenders were emerging from pandemic pressures with real strength.
Across the STOXX 600, more than half the companies had now reported their quarterly results. Of those, 73% had beaten profit expectations—well above the historical norm of 51%. Food and beverage stocks, utilities, and chemicals led the day's gains. Volkswagen, Europe's largest automaker, inched up 0.1% after raising its operating margin target for the full year, a modest move that nonetheless reflected growing confidence in the business environment.
The economic backdrop reinforced the earnings story. German industrial orders surged in March, driven by stronger domestic demand for consumer goods. Britain's services sector, meanwhile, recorded its fastest growth in more than seven years. These were not marginal improvements but genuine signs of economic momentum. Yet there were complications. Novavax and Moderna, both U.S. drugmakers with Frankfurt listings, fell close to 10% after President Joe Biden announced support for waiving intellectual property protections on COVID-19 vaccines—a move that threatened their pricing power and profit margins. Telecom Italia dropped 5.3% on reports that the Italian government was abandoning plans for a unified broadband network.
In London, the FTSE 100 rose 0.2% as traders braced for the Bank of England's monetary policy decision. The central bank was expected to signal that Britain's economic recovery would be stronger than previously forecast, and possibly hint at slowing its pandemic-era stimulus measures. Such hawkish signals could pressure the index, analysts warned, potentially pushing it below 7,000. British retailers showed resilience: Next gained 3.0% after raising full-year profit guidance, while Superdry rallied 12.0% on news it had returned to growth in the fourth quarter, buoyed by online and wholesale channels. The market was reading the data as a story of genuine recovery—one strong enough that central banks might soon begin stepping back from emergency support. Whether that would sustain the rally remained to be seen.
Citas Notables
The increasing strength of the UK economy's rebound will cause the central bank to mull over tapering its current stimulus support. Any hawkish signals could well send the FTSE back below 7,000.— Connor Campbell, market analyst at SpreadEX
La Conversación del Hearth Otra perspectiva de la historia
Why did the market barely move when earnings were so strong?
Because the good news was already priced in. Investors had been expecting strong results, so when companies delivered, it confirmed what the market already believed. The real surprise would have been disappointment.
What about those vaccine companies falling 10%? That seems like a big move.
Biden's support for waiving patent protections threatened their entire business model. If other countries can manufacture these vaccines without paying royalties, Novavax and Moderna lose their pricing power. It's not about the science—it's about who gets to profit from it.
The Bank of England decision seems to be the real pivot point here.
Exactly. As long as central banks are flooding markets with stimulus, stocks have a safety net. But if the BoE signals it's ready to taper, that changes the calculus. Higher rates mean future earnings are worth less in today's money. That's when you see real volatility.
So the market is actually nervous underneath all this optimism?
Not nervous exactly. More like standing at a crossroads. The economy is genuinely recovering—the data proves it. But that recovery is what might force central banks to stop supporting asset prices. The market is celebrating the recovery while quietly wondering if it's celebrating its own end.
Is 73% of companies beating expectations actually that impressive?
It's 22 percentage points above normal. That's significant. It suggests companies came into earnings season with conservative guidance, then beat it. That's a sign of confidence, not just luck.